Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Southport
Clinical trial register · Australia

Clinical Trials in Southport, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca8 AbbVie7 Merck Sharp & Dohme LLC5 Janssen Research & Development, LLC5 Eli Lilly and Company5
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Southport

151 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Novartis Pharmaceuticals
Phase 2
344
Southport, Nedlands
2026-08-24
Recruiting
AstraZeneca
Phase 3
7,000
Castle Hill, Fitzroy, Gosford, Melbourne, Perth, Southport, St Leonards, Wollongong
2026-08-21
Recruiting
VarmX B.V.
Phase 3
800
Herston, South Brisbane, Southport, Fitzroy, Melbourne, Murdoch
2026-08-18
Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
NCT07625644Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc
DrugsEtoposide·Atezolizumab·Carboplatin
SystImmune Inc.
Phase 3
550
Garran, Southport, Bedford Park
2026-08-04
Recruiting
A Study of ARC-02 in B-cell NHL
NCT07691606B-cell Non Hodgkin Lymphoma
DrugRituximab
Taiho Oncology, Inc.
Phase 1
140
Clayton, Melbourne, Nedlands, Southport
2026-06-22
Recruiting
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
NCT07623369Solid Tumor, Non-small Cell Lung Cancer, Hepatocellular Carcinoma, Colorectal Cancer
Huahui Health
Phase 1
299
Waratah, Southport
2026-06-11
Recruiting
BioNTech SE
Phase 3
736
Southport
2026-04-22
Recruiting
Mediar Therapeutics
Phase 2
85
Southport, Woolloongabba, Heidelberg
2026-04-16
Active, closed
RDC Clinical Pty Ltd
Phase 4
36
Southport
2026-03-26
Recruiting
Astellas Pharma Global Development, Inc.
Phase 2
240
Southport
2026-03-12
Recruiting
Incyte Corporation
Phase 3
700
Port Macquarie, Randwick, Waratah, Westmead, Wollongong, Southport, Townsville, Woolloongabba
2026-03-05
Recruiting
ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
NCT07238075Advanced Malignancy, Advanced Solid Cancers, Metastatic Solid Tumors
Adcytherix SAS
Phase 1
290
Sydney, Birtinya, Southport, Adelaide, Nedlands
2026-02-23
Recruiting
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
NCT07363590Systemic Lupus Erythematosus, Rheumatoid Arthritis
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1
21
Southport
2026-02-19
Recruiting
Boehringer Ingelheim
Phase 3
286
Concord, Kingswood, Kogarah, Westmead, Herston, Southport, Adelaide, AT Albans
2026-02-16
Recruiting
Eli Lilly and Company
Phase 3
800
Adelaide, Bedford Park, Box Hill, Brisbane, Heidelberg West, Maroochydore, Southport, Spearwood
2026-02-10
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Box Hill, Brisbane, Clayton, Fitzroy, Melbourne, Murdoch, Nedlands, Southport
2026-02-04
By invitation
Immunovant Sciences GmbH
Phase 2
372
South Brisbane, Southport, Perth, St Leonards, Sydney
2026-01-26
Recruiting
Generate Biomedicines
Phase 3
786
Coffs Harbour, Southport
2026-01-20
Recruiting
Regeneron Pharmaceuticals
Phase 3
915
Benowa, Brisbane, Southport, Melbourne, Perth
2026-01-02
Recruiting
EBR Systems, Inc.
Not applicable
40
Birtinya, Herston, Southport, Woolloongabba
2025-12-18
Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
NCT06887348Melanoma, Metastatic Melanoma, Advanced Solid Tumor, Hepatocellular Carcinoma
Replimune, Inc.
Observational
50
Southport
2025-12-12
Recruiting
Amgen
Phase 3
750
Waratah, Auchenflower, Southport, Clayton, East Melbourne
2025-11-28
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Kogarah, New Lambton Heights, Westmead, Clayton, Heidelberg, Murdoch, Southport
2025-11-11
Recruiting
Eli Lilly and Company
Phase 3
1,205
Box Hill, Brisbane, Canberra, Geelong, Meadowbrook, Perth, Southport, St Leonards
2025-10-31
Recruiting
Eli Lilly and Company
Phase 3
1,630
Ballarat Central, Camperdown, Launceston, Malvern, Randwick, Shepparton, Southport, St Leonards
2025-10-22
Recruiting
Adze Biotechnology Australia Pty Ltd
Phase 1
30
Southport, Adelaide, Clayton
2025-10-01
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
30
Gosford, Parkville, Southport
2025-09-19
Recruiting
Zydus Therapeutics Inc.
Phase 2
240
Caulfield South, Sydney, Southport
2025-09-17
Recruiting
The University of Queensland
Not applicable
1,148
Caboolture, Redcliffe, Robina, Southport
2025-08-18
Recruiting
BioNTech SE
Phase 1/2
1,438
Blacktown, Darlinghurst, Wollstonecraft, Southport, Adelaide, Frankston, Heidelberg, Melbourne
2025-08-12
Recruiting
Celcuity Inc
Phase 3
1,180
Birtinya, Heidelberg, Adelaide, Nedlands, Southport, Wahroonga, Westmead, Woodville
2025-07-24
Recruiting
Bristol-Myers Squibb
Phase 3
586
Birtinya, Herston (rbwh Grounds), Southport, Ivanhoe
2025-07-21
Recruiting
Daiichi Sankyo
Phase 2
130
Adelaide, Australia, Darlinghurst, Melbourne, Perth, Southport, Sydney
2025-07-18
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Garran, Liverpool, St Leonards, Auchenflower, Birtinya, Herston, Milton, Southport
2025-06-25
Active, closed
EIP Pharma Inc
Phase 2
90
Campbelltown, Liverpool, Birtinya, Brisbane, Southport, Box Hill, Heidelberg, Melbourne
2025-06-20
Recruiting
Immunovant Sciences GmbH
Phase 2
210
Sydney, Warrawong, Brisbane, Douglas, Southport, Box Hill, Geelong, Parkville
2025-06-19
Recruiting
BlueRock Therapeutics
Phase 3
102
Randwick, Southport, Woolloongabba, Clayton, Melbourne, Parkville
2025-06-17
Active, closed
Paradigm Biopharmaceuticals Ltd.
Phase 3
466
Brookvale, Charlestown, Miranda, Wollongong, South Brisbane, Southport, Adelaide, Stepney
2025-05-29
Recruiting
Biogen
Phase 3
180
Concord, Kogarah, Liverpool, Westmead, Douglas, Herston, Southport, Clayton
2025-05-22
Recruiting
Biogen
Phase 3
454
New Lambton, New South Wales, St Leonards, Westmead, Douglas, Herston, Southport, Woolloongabba
2025-05-08
Recruiting
Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
NCT06714006Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PYC Therapeutics
Phase 1
166
Southport, Concord, Liverpool, Randwick, Wahroonga, Westmead, South Brisbane, Fitzroy
2025-04-07
Recruiting
Gilead Sciences
Phase 3
695
New South Wales, Queensland, Southport, Adelaide, Fitzroy, Nedlands
2025-04-04
Recruiting
Sanofi
Phase 1/2
1,560
Bruce, Maroubra, Sydney, Albion, Morayfield, Southport, Melbourne
2025-03-27
Active, closed
Immutep S.A.S.
Phase 3
756
Elizabeth Vale, Greenslopes, Melbourne, Southport, Subiaco, Tiwi, Waratah, Wollongong
2025-03-21
Active, closed
Celgene
Phase 3
960
Campbelltown, Darlinghurst, Macquarie University, Port Macquarie, Wahroonga, Greenslopes, Southport, Adelaide
2025-03-13
Recruiting
AstraZeneca
Phase 3
5,000
Adelaide, Darlinghurst, Elizabeth Vale, Gosford, North Tamworth, Perth, Southport, St Leonards
2025-03-03
Recruiting
Bayer
Phase 2
111
Blacktown, Sydney, Southport
2025-02-13
Active, closed
Bristol-Myers Squibb
Phase 1/2
360
Southport
2025-02-12
Recruiting
Dianthus Therapeutics
Phase 3
256
Liverpool, Randwick, Saint Leonards, Sydney, Southport, Melbourne
2025-02-10
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Camperdown, Kingswood, Waratah, Southport, Tugun, Heidelberg, North Melbourne, Murdoch
2025-01-28
Active, closed
AbbVie
Phase 1
4
Sydney, Southport, Heidelberg, Perth
2025-01-27
Recruiting
Implementing Surgery School Prehabilitation Using Telehealth
NCT06631872Adults Waiting to Undergo Lung Cancer or Major Abdominal, Open or Video Assisted Cancer Surgery
University of Melbourne
Not applicable
515
New Lambton Heights, Waratah, Southport, Woolloongabba, Burnie, Launceston, Heidelberg, Melbourne
2025-01-22
Recruiting
BioNTech SE
Phase 1/2
248
Southport, Adelaide, Clayton, Randwick
2025-01-13
Active, closed
argenx
Phase 3
154
Parkville, Southport, Sydney, Woolloongabba
2024-12-18
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 3
1,714
Westmead, Brisbane, Southport, Parkville, Perth
2024-12-18
Active, closed
H. Lundbeck A/S
Phase 3
401
Liverpool, Westmead, Southport, Melbourne
2024-12-03
Recruiting
AstraZeneca
Phase 3
1,160
Darlinghurst, Hyde Park, Southport, Wollongong
2024-11-27
Active, closed
Genmab
Phase 3
191
Camperdown, Sydney, Southport, Bedford Park, Perth, Subiaco, Fitzroy, Wendouree
2024-11-25
Recruiting
AstraZeneca
Phase 3
1,160
Darlinghurst, Hyde Park, Southport, Wollongong
2024-11-18
Active, closed
A Study of DM001 in Patients With Advanced Solid Tumors
NCT06475937Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Solid Carcinoma
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
Phase 1
128
South Brisbane, Southport, Clayton
2024-10-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Waratah, Southport, Woolloongabba, Ballarat, Nedlands
2024-10-21
Active, closed
Novartis Pharmaceuticals
Phase 2
251
North Ryde, Herston, Caulfield South, Southport
2024-10-17
Recruiting
Xencor, Inc.
Phase 1/2
270
Adelaide, Joondalup, Melbourne, Nedlands, South Brisbane, Southport, Wollongong
2024-10-10
Active, closed
ModernaTX, Inc.
Phase 3
37,864
Bruce, Coffs Harbour, Darlinghurst, Kanwal, Maroubra, Herston, Southport, Norwood
2024-09-24
Active, closed
argenx
Phase 3
141
Box Hill, Melbourne, Southport
2024-09-18
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Concord, Gosford, Kingswood, Kogarah, Liverpool, Port Macquarie, Pialba, Southport
2024-08-30
Recruiting
Vor Biopharma
Phase 3
180
Concord, Douglas, Southport
2024-07-17
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Camperdown, Birtinya, South Brisbane, City of Burnside, Box Hill, Southport
2024-06-25
Recruiting
AstraZeneca
Phase 3
240
Camperdown, Nedlands, New Lambton, Southport, Woodville South
2024-06-20
Active, closed
Celgene
Phase 3
850
Gosford, Sydney, Westmead, Tiwi, Birtinya, Southport, Frankston, Heidelberg
2024-06-19
Recruiting
X4 Pharmaceuticals
Phase 3
176
Nedlands, Southport, Wendouree
2024-06-06
Recruiting
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
NCT06305962PDL1 Gene Mutation, Non Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), TNBC, Triple Negative Breast Cancer
Radiopharm Theranostics, Ltd
Early Phase 1
30
Kingswood, Wollongong, Southport, Adelaide, Murdoch
2024-06-03
Recruiting
The George Institute
Phase 4
162
Camperdown, Randwick, St Leonards, Warners Bay, Southport, Melbourne, Parkville
2024-06-03
Recruiting
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
NCT06351631Thrombocythemia, Essential, Primary Myelofibrosis, Myelofibrosis, Post-polycythemia Vera Myelofibrosis
DrugBomedemstat
Merck Sharp & Dohme LLC
Phase 3
400
Camperdown, St Leonards, Buderim, Southport, Adelaide, Clayton
2024-05-23
Active, closed
Avecho Biotechnology
Phase 3
519
North Sydney, Sydney, Southport, Clayton, Nedlands
2024-05-16
Recruiting
W.L.Gore & Associates
Observational
2,000
New Lambton Heights, Southport, Bedford Park, Melbourne, Perth, Sydney
2024-05-07
Active, closed
Erasca, Inc.
Phase 3
78
Waratah, Southport, Woolloongabba, Melbourne, Nedlands
2024-04-29
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Canberra, Clayton, Concord, Herston, Liverpool, Perth, Southport, St Albans
2024-03-29
Recruiting
Daiichi Sankyo
Phase 2/3
860
Adelaide, Melbourne, Southport, St Leonards
2024-02-27
Recruiting
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
NCT06244771Advanced Solid Tumors With KRAS G12C Mutations, Solid Tumor, Adult, Unresectable Solid Tumor, Metastatic Solid Tumor
Frontier Medicines Corporation
Phase 1/2
403
Macquarie Park, Southport, Kurralta Park, North Adelaide, Box Hill, Nedlands
2024-02-12
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Adelaide, Box Hill, Darlinghurst, Fitzroy, Southport, West Perth, Wollongong
2024-01-22
Active, closed
DualityBio Inc.
Phase 3
541
Camperdown, Kingswood, Liverpool, Sydney, Birtinya, South Brisbane, Southport, Townsville
2024-01-18
Active, closed
Syndax Pharmaceuticals
Phase 2
145
Camperdown, Birtinya, Brisbane, South Brisbane, Southport, West Mackay, Clayton, Perth
2023-12-11
Recruiting
Eikon Therapeutics
Phase 1/2
156
Randwick, South Brisbane, Southport, Sydney, Woolloongabba, Frankston
2023-12-11
Active, closed
argenx
Observational
413
Parkville, Southport, Woolloongabba
2023-11-29
Recruiting
A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)
NCT05417516Breast Neoplasm Female, Radiotherapy, Cosmetic Outcome
Ontario Clinical Oncology Group (OCOG)
Phase 3
910
Darlinghurst, Hurstville, North Sydney, Bundaberg, Southport, Tugun, Urraween, Adelaide
2023-11-20
Active, closed
AstraZeneca
Phase 3
1,835
Gosford, Meadowbrook, Perth, Reservoir, Southport
2023-11-07
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
NCT06022029Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Lymphoma, Non-Hodgkin
DrugCemiplimab
OncoNano Medicine, Inc.
Phase 1
168
Darlinghurst, Wollongong, Buderim, Southport, Woolloongabba, Bedford Park, Subiaco
2023-10-13
Active, closed
Acuity Polymers, Inc.
Not applicable
387
Adelaide, Cooks Hill, Southport
2023-10-01
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Albury, Campbelltown, Camperdown, Gosford, New Lambton Heights, Saint Leonards, Wentworthville, Southport
2023-04-18
Recruiting
Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).
NCT05720130Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
Drug[²¹²Pb]Pb-ADVC001
AdvanCell Pty Limited
Phase 1/2
100
Brisbane, Southport
2023-03-15
Active, closed
AbbVie
Phase 3
520
Westmead, Southport, Ballarat, Clayton, Malvern, Melbourne, Richmond, Subiaco
2023-03-15
Active, closed
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
NCT05478304Ischemic Stroke, Systemic Embolism
AtriCure, Inc.
Not applicable
6,573
Southport, Clayton, Fitzroy
2023-01-25
Active, closed
Celcuity Inc
Phase 3
701
Adelaide, Fitzroy, Frankston, Nedlands, South Brisbane, Southport, Wahroonga, Woodville
2022-12-08
Active, closed
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
NCT05544552Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor, Urothelial Carcinoma
DrugTYRA-300
Tyra Biosciences, Inc
Phase 1/2
310
Macquarie Park, Southport, Woolloongabba, Heidelberg, Melbourne, Nedlands
2022-11-22
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Bedford Park, Footscray, Kurralta Park, Liverpool, Newcastle, Southport, Sydney, Westmead
2022-08-17
Recruiting
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
NCT05376267Cardiac Arrest, Out-Of-Hospital, Hypothermia, Induced, Hypoxia-Ischemia, Brain
University of Michigan
Not applicable
900
Brisbane, Douglas, Southport, North Adelaide, Clayton, Parkville, Nedlands
2022-08-05
Active, closed
AstraZeneca
Phase 3
341
Fremantle, Southport, Waratah NSW, Westmead
2022-08-03
Recruiting
Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
NCT05072314Breast Cancer, Breast Cancer Female, Breast Conserving Surgery, Mastectomy
DrugLidocaine
Monash University
Phase 3
4,300
Kingswood, Mount Druitt, Sydney, Brisbane, Coopers Plains, Mackay, Rockhampton, Southport
2022-07-27
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Southport, Townsville, North Adelaide, Hobart, Geelong, Melbourne
2022-07-14
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
83
Gosford, Liverpool, Randwick, St Leonards, Sydney, Westmead, Southport, Frankston
2022-05-30
Active, closed
Eli Lilly and Company
Phase 3
925
Camperdown, Coffs Harbour, Darlinghurst, Liverpool, Macquarie University, South Brisbane, Southport, Woolloongabba
2022-04-14
Active, closed
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
NCT05002127Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
DrugsEvorpacept·Ramucirumab·Herceptin·Taxol
ALX Oncology Inc.
Phase 2/3
127
Southport, Clayton
2022-01-15
Active, closed
Ascendis Pharma Oncology Division A/S
Phase 1/2
320
Adelaide, Brisbane, Frankston, Southport, Toorak Gardens, Waratah
2022-01-11
Active, closed
JOTEC GmbH
Observational
30
Melbourne, Perth, Saint Leonards, Southport
2022-01-01
Active, closed
Olema Pharmaceuticals, Inc.
Phase 1
60
Waratah, Westmead, South Brisbane, Southport, Clayton, Frankston, Geelong, Nedlands
2021-12-10
Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
NCT04996875Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN), Mast Cell Leukemia (MCL), Aggressive Systemic Mastocytosis (ASM)
DrugBezuclastinib
Cogent Biosciences, Inc.
Phase 2
140
Kingswood, Southport, Melbourne N.
2021-11-09
Recruiting
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
NCT04754022Disorder, Heart, Postoperative, Cardiac Surgery
Unity Health Toronto
Not applicable
1,440
Adelaide, Camperdown, Randwick, Westmead, Southport, Bedford Park, Clayton, Fitzroy
2021-11-01
Active, closed
Paradigm Biopharmaceuticals USA (INC)
Phase 2/3
602
Maroubra, Southport, Stepney, Nedlands
2021-10-19
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
DrugsBosutinib·Asciminib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 3
405
Kingswood, Port Macquarie, Adelaide, Southport
2021-10-06
Active, closed
Janssen Research & Development, LLC
Phase 1
166
Fitzroy, Melbourne, Southport, Wollongong
2021-09-22
Active, closed
The Cryopreserved vs. Liquid Platelets Trial
NCT03991481Surgical Blood Loss, Hemorrhage
Australian and New Zealand Intensive Care Research Centre
Phase 3
388
Sydney, Brisbane, Douglas, Southport, Fitzroy, Heidelberg
2021-08-17
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Waratah, Wollstonecraft, Southport, Heidelberg, Perth
2021-08-04
Recruiting
Janssen Research & Development, LLC
Phase 3
199
North Melbourne, Southport
2021-07-15
Recruiting
Australian and New Zealand Intensive Care Research Centre
Phase 2
450
Sydney, Wollongong, Birtinya, Brisbane, Southport, Adelaide, Geelong, Melbourne
2021-07-15
Active, closed
Kirby Institute
Phase 3
650
Parramatta, Sydney, Southport, Carlton, Melbourne
2021-07-08
Active, closed
The Netherlands Cancer Institute
Phase 3
423
Sydney, Brisbane, Gateshead, Melbourne, Murdoch, Southport
2021-07-08
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
NCT04771130Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm
DrugsPosaconazole·Sonrotoclax·Azacitidine
BeOne Medicines
Phase 1/2
260
Concord, Kogarah, Orange, Southport, Clayton, Fitzroy, Heidelberg, Melbourne
2021-05-24
Recruiting
Janssen Research & Development, LLC
Phase 1/2
420
Clayton, Perth, Southport
2021-05-19
Active, closed
Pfizer
Phase 3
599
Camperdown, Wollongong, Brisbane, Southport, Woodville South, East Melbourne, Malvern, Richmond
2021-05-12
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
NCT04752722Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer
DrugPhase 2
enGene, Inc.
Phase 1/2
350
Wahroonga, Southport, Windsor Gardens
2021-04-22
Active, closed
Incyte Corporation
Phase 3
654
Kogarah, Sydney, Wollongong, Southport, Adelaide, Bedford Park, Melbourne, St Albans
2021-04-15
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Camperdown, Kingswood, Liverpool, Westmead, Southport, Adelaide, Elizabeth Vale, Fitzroy
2021-04-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Campbelltown, Kingswood, Waratah, Southport, Frankston, Heidelberg, St Albans
2020-12-08
Recruiting
University of Melbourne
Not applicable
240
Newcastle, Sydney, Brisbane, Southport, Adelaide, Melbourne, Parkville
2020-11-15
Active, closed
AbbVie
Phase 3
527
Wollongong, South Brisbane, Southport, Elizabeth Vale, Clayton
2020-09-30
Active, closed
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
NCT04140526Non Small Cell Lung Cancer, Advanced Solid Tumor, Metastatic Melanoma, Metastatic Head and Neck Carcinoma
DrugsGotistobart·Taxotere·Docetaxel·Keytruda
OncoC4, Inc.
Phase 1/2
733
New Lambton Heights, Southport, Adelaide, Bedford Park
2020-09-16
Active, closed
AbbVie
Phase 3
531
Blacktown, Kogarah, Port Macquarie, Southport, Adelaide, Fitzroy Melbourne, Heidelberg
2020-09-10
Active, closed
Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia
NCT05524077Heart Disease Structural Disorder, Ventricular Tachycardia, Cardiomyopathy, Dilated, Sarcoidosis
Western Sydney Local Health District
Not applicable
162
Camperdown, Kingswood, New Lambton Heights, Saint Leonards, Westmead, Chermside, Southport, Adelaide
2020-07-08
Active, closed
Stryker Neurovascular
Not applicable
248
Liverpool, Nedlands, Southport
2020-07-07
Active, closed
Epizyme, Inc.
Phase 3
599
Adelaide, Bedford Park, Clayton, Geelong, Nedlands, Frankston, Hobart, Southport
2020-06-11
Recruiting
University of Leicester
Not applicable
2,104
Garran, Liverpool, St Leonards, Westmead, Wollongong, Chermside, Douglas, Southport
2020-03-10
Active, closed
Auckland City Hospital
Not applicable
550
Sydney, Southport, Woolloongabba
2019-11-28
Active, closed
Bristol-Myers Squibb
Phase 3
790
Waratah, Westmead, Wollstonecraft, Cairns, Greenslopes, Herston, Southport, Box Hill
2019-10-28
Active, closed
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
NCT04050436Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
DrugsVusolimogene Oderparepvec·Cemiplimab
Replimune, Inc.
Phase 2
231
Camperdown, Wollongong, Southport, Clayton, Melbourne, Nedlands
2019-10-08
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Coffs Harbour, North Sydney, Sydney, Waratah, Westmead, Greenslopes, South Brisbane, Southport
2019-08-09
Recruiting
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction
NCT05651347Fetal Growth Retardation, Stillbirth and Fetal Death, Pregnancy Preterm
DrugMelatonin
Monash University
Phase 3
336
Camperdown, Newcastle, South Brisbane, Southport, North Adelaide, Clayton, Heidelberg, Parkville
2019-05-29
Active, closed
AbbVie
Phase 3
964
Garran, Herston, Maroochydore, Southport, Bedford Park, Camberwell, Clayton
2019-03-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
North Sydney, Westmead, Cairns, Southport, Woolloongabba, Adelaide, Kurralta Park, Melbourne
2018-09-12
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
North Sydney, Waratah, Greenslopes, Southport, Bedford Park, Murdoch
2018-04-11
Active, closed
AbbVie
Phase 3
1,336
South Brisbane, Southport, Elizabeth Vale, Camberwell
2018-04-09
Active, closed
Pfizer
Phase 3
1,054
Camperdown, Darlinghurst, Port Macquarie, Auchenflower, Brisbane, Chermside, South Brisbane, Southport
2017-12-18
Active, closed
AbbVie
Phase 3
950
Macquarie University, South Brisbane, Southport, Clayton, Fitzroy Melbourne, Murdoch
2017-01-31
Recruiting
Neurovascular Product Surveillance Registry
NCT02988128Intracranial Aneurysm, Stroke, Ischemic
Medtronic Neurovascular Clinical Affairs
Observational
4,000
Southport
2016-12
Recruiting
Duration of Anti-PD-1 Therapy in Metastatic Melanoma
NCT02821013Unresectable/Metastatic Melanoma
Canadian Cancer Trials Group
Phase 3
614
Victoria, Coffs Harbour, Waratah, Westmead, Birtinya, Cairns, Southport, Woodville
2016-10-31
Active, closed
AstraZeneca
Phase 3
1,118
Box Hill, Gosford, Kogarah, Melbourne, Port Macquarie, Southport, St Leonards
2015-07-21
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Adelaide, Ashford, Camperdown, Herston, Liverpool, Malvern, Melbourne, Southport
2014-11-26
Active, closed
Eli Lilly and Company
Phase 3
669
South Brisbane, Southport, Kurralta Park, East Bentleigh, Subiaco
2014-07-22
Active, closed
Improving the Treatment for Women With Early Stage Cancer of the Uterus
NCT01686126Complex Endometrial Hyperplasia With Atypia, Grade 1 Endometrial Endometrioid Adenocarcinoma
DrugsLevonorgestrel·Mirena·Metformin
Queensland Centre for Gynaecological Cancer
Phase 2
165
Camperdown, Auchenflower, Brisbane, Greenslopes, South Brisbane, Southport, Townsville, Adelaide
2012-12
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Westmead, Chermside, Murdoch, Southport
2012-01
Recruiting
Medtronic
Observational
20,000
Chermside, Douglas, Murdoch, Southport
1983-01
Rows per page Showing 1–151 of 151
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-australia/city/southport

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 151 of those studies with a site in Southport.

How many clinical trials are recruiting in Southport?

82 of the 151 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 68 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Southport), 151 studies
PhaseStudiesRecruitingShare
Phase 3793652.3%
Phase 2181111.9%
Phase 1/215119.9%
Not applicable1277.9%
Phase 11287.9%
Observational754.6%
Phase 2/3523.3%
Phase 4211.3%
Early Phase 1110.7%

Most active sponsors

Lead sponsors with the most studies (Southport)
Lead sponsorStudiesRecruiting
AstraZeneca85
AbbVie70
Bristol-Myers Squibb52
Eli Lilly and Company53
Janssen Research & Development, LLC53
Merck Sharp & Dohme LLC53
Novartis Pharmaceuticals42
argenx30
BioNTech SE33
Alexion Pharmaceuticals, Inc.21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.